Albert Chen

@skyestarfyre @captgouda24 Ofc grad school should not be like industry in every way - academia should select for those passionate for academia, if ppl want money they should get an industry job. But keeping wages near a line of unlivability selects for rich kids and leaves a lot of talent on the table.

I want to live in a world where people who choose to go to graduate school are smart enough to understand the choice they are making. Plenty of lower-income students can and do excel in graduate programs. Your original point was about people with dependents or disabilities, who do not necessarily have a lower-income financial background. Mine was that graduate programs should not have an inordinate obligation to support such students any more than other “employers,” if we event want to think about these programs as employment rather than education in the first place. Do grad students work? Yes. They also do other things that are more nebulous and for which a wage or salary is not an appropriate form of financial support.

Harvard should crush the strikers. Don't give them an inch. The good grad students are there to do research, not quarrel.

@skyestarfyre @captgouda24 Do you want to live in a world where all academics are just rich kids?

No more or less than such people deserve a chance to undertake any adult occupation for which they are qualified. Graduate programs should not be under any special obligation to absorb the economic cost associated with admitting such students, and those students should understand that graduate school may impose financial difficulties on them.

@captgouda24 For a single person with no dependents, sure, it’s livable. Should someone with dependents not deserve to have a chance to go to grad school? What about someone with disabilities?

The notion that grad students can't make ends meet is absolutely ridiculous to me. I live a mile away from Harvard. I am essentially a grad student with no stipend and no support. I'm making it work. Why can't they? The people who this screws are me -- marginal admits.

@captgouda24 Harvard slashed admissions of many programs in half while raising a record amount of money and growing their endowment $3.7B to $57B. The cuts in grad enrollment were so controversial that a dean who opposed the cuts was fired (Lichtman). All this before the strike

The point of a grad student union is to screw over those on the outside in favor of those on the inside. To squeeze out a few thousand dollars per person, we're denying potential students in the future. It's appallingly selfish. So no, I can't support the strikers.

@GHarmange @NatureComms Congrats Guillaume!!

My thesis work on drug resistance in melanoma is now published in @NatureComms! nature.com/articles/s4146…

We have released a preprint “Targeting AAV vectors to the CNS via de novo engineered capsid-receptor interactions”. We developed gene delivery vectors with known mechanisms of action & predictable tropisms by targeting AAVs to specific proteins. tinyurl.com/2ndsuvp6

@slavov_n @slavovLab @GrayHuffman congrats gray!!

Congratulation to the newest PhD from @slavovLab, Dr. Huffman!

@slavov_n @NUBioE1 @NortheasternCOE @harrisonspecht Congrats Dr. @harrisonspecht !!!!!!!!

Congrats to Dr. Specht, the newest PhD from @NUBioE1 and @NortheasternCOE! Mentoring and supporting the growth of students like @harrisonspecht is a huge privilege of being an academic PI.

1⃣Developing a method is just the first step. ✔️ 2⃣Helping others adopt it is the second step 👇 Thanks to @aleks_petelski, @edemmott and the entire @slavovLab team for this @NatureProtocols article! nature.com/articles/s4159…

And its out! My/@Emmottlab first PI paper “Characterising proteolysis during SARS-CoV-2 identifies viral cleavage sites and cellular targets with therapeutic potential”. nature.com/articles/s4146… This was a huge collaborative effort with 19 authors spanning 4 continents!

My awesome sister just released her book! Uplifted tells the personal stories of how 21 Asian American entrepreneurs built their businesses, overcame their greatest challenges, and drew strength from their identities to uplift others. kickstarter.com/projects/uplif…

We've created an interactive website to visualize >100,000 experimental measurements of how mutations to #SARSCoV2 RBD affect binding by antibodies & sera: jbloomlab.github.io/SARS2_RBD_Ab_e… Explore it to examine a wealth of information about the antigenic effects of viral mutations. (1/n)

Version 2 of covidcg.org is up! New data selection interface, now able to handle all 733,480+ SARS2 genomes from GISAID. Please send us your feedback and help us to debug the site!

@winocm @Ayjchan @shingheizhan @CovidCg @DevermanLab We also have a version of the site that is run off of GenBank data instead of GISAID data (genbank.covidcg.org). It has a few more features enabled, like per-sequence metadata/SNV downloads

We’ve updated our SARS-CoV-2 preprint investigating proteolysis by viral and host enzymes during SARS-CoV-2 infection! Lots of new data, and an author list now covering 4 countries on 3 continents! Read it here: biorxiv.org/content/10.110…

Our joint single-cell analysis of proteins & RNAs in differentiating macrophages appeared in @GenomeBiology genomebiology.biomedcentral.com/articles/10.11… (preprint: biorxiv.org/content/10.110…) We analyzed ~ 3,000 proteins and RNAs across single monocytes and macrophages, and found ...

New paper: Single-cell proteomic and transcriptomic analysis of macrophage heterogeneity using SCoPE2. genomebiology.biomedcentral.com/articles/10.11… now published in @GenomeBiology

I’m delighted to share the first @emmottlab preprint! In this paper we study protease activity in #SARSCOV2 infected cells. We found multiple unknown cleavage sites in viral proteins, and novel cellular targets of the viral proteases essential for virus replication.

Our talk just got bumped earlier to 5 PM CDT / 6 PM EST. The closing talk for the @ASGCTherapy COVID-19 symposium. Grab your happy hour drink of choice and tune in for our 15-min talk! 🍻🍷🧋🍵🍼🧃🥤🍾🍸🥂🍹🧉🥛🧬 webcastregister.live/asgct_covid19_…

Heads up on a 2-day all-star @ASGCTherapy COVID-19 symposium starting tomorrow. Dr Fauci is the opening keynote. @atchen_ @DevermanLab @shingheizhan our group is giving the last talk on Wednesday afternoon 5:15PM CDT! asgct.org/events/covid-s…